# US 2026/0256858 A1 · Amanita Muscaria Mushroom Extracts and Products, and Improved Processes for Producing Extracts of Amanita Muscaria Mushrooms at Kilogram Scale

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0256858 A1
- Document ID: US20260256858A1
- Status: Published application
- Kind: A1
- Application number: 19/157,676
- Filed: 2024-02-16
- Published: 2026-09-03
- Earliest claimed: 2023-02-16
- Assignees: Psyched Wellness Ltd.
- Applicants: Psyched Wellness Ltd.
- Inventors: Jeffrey STEVENS; Brian TANCOWNY; Deepank UTKHEDE
- Web page: https://patentgrep.com/patent/US20260256858A1

## CPC

- A61K 36/07: Basidiomycota, e.g. Cryptococcus
- A23G 3/368: {containing vitamins, antibiotics}
- A23L 2/38: Other non-alcoholic beverages (drinks from legumes A23L11/60)
- A23L 2/52: Adding ingredients (adding preservatives A23B70/10)
- A23L 2/56: Flavouring or bittering agents (sweeteners A23L2/60)
- A23L 2/72: by filtration
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/0078: {for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions}
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/42: Oxazoles
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- B01D 69/02: characterised by their properties
- B01D 69/04: Tubular membranes
- C12Q 1/06: Quantitative determination
- G01N 33/6812: {Assays for specific amino acids}
- G01N 33/84: involving inorganic compounds or pH
- A61K 2236/15: involving mechanical treatment, e.g. chopping up, cutting or grinding
- A61K 2236/17: involving drying, e.g. sun-drying or wilting
- A61K 2236/331: using water, e.g. cold water, infusion, tea, steam distillation or decoction
- A61K 2236/333: using mixed solvents, e.g. 70% EtOH
- A61K 2236/37: Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
- A61K 2236/53: Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
- B01D 2325/0283: Pore size
- G01N 30/72: Mass spectrometers {(mass spectrometers per se H01J49/00)}
- G01N 2333/245: Escherichia (G)
- G01N 2333/255: Salmonella (G)
- G01N 2333/375: from Basidiomycetes
- H01J 49/105: {using high-frequency excitation, e.g. microwave excitation, Inductively Coupled Plasma [ICP]}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23G: COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)

## Abstract

Disclosed herein are processes for extracting muscimol from Amanita mushrooms, and more particularly, from Amanita muscaria, including processes that increase muscimol content and decrease ibotenic acid content, and further including improved processes that produce extract at scale, such as at kilogram scale. In some aspects are methods for selecting Amanita mushroom biomass suitable for the disclosed extraction methods, so as to produce extracts and products that are safe and beneficial for human use. Also disclosed are numerous compositions and formulations made with disclosed extracts, including beverage formulations, having a variety of improvements and advantages over previously known products made from Amanita muscaria.

## Claims

### Claim 1

A method for producing a wellness-promoting Amanita muscaria extract from mushroom biomass, comprising:
i. selecting mushroom biomass for extraction;
ii. performing an aqueous extraction of the biomass in the presence of heat to produce the extract;
iii. filtering the extract;
iv. reducing the pH of the extract;
V. heating the extract to reflux; and
vi. collecting the wellness-promoting Amanita muscaria extract.

### Claim 2 (depends on 1)

The method of claim 1, wherein the biomass is dehydrated prior to performing the aqueous extraction.

### Claim 3 (depends on 2)

The method of claim 2, wherein the biomass is dehydrated to a moisture content of about 1% to about 10%, about 2% to 7%, about 4% to 7%, or about 2%, 3%, or 4% prior to performing the aqueous extraction.

### Claim 4 (depends on 1)

The method of claim 1, wherein the biomass is ground into a powder prior to performing the aqueous extraction.

### Claim 5 (depends on 1)

The method of claim 1, wherein selecting the biomass for extraction comprises subjecting the biomass to a quality control analysis.

### Claim 6 (depends on 5)

The method of claim 5, wherein the analysis comprises chemical analysis.

### Claim 7 (depends on 6)

The method of claim 6, wherein the chemical analysis comprises a chromatography technique.

### Claim 8 (depends on 6)

The method of claim 6, wherein the chemical analysis comprises any of high-performance liquid chromatography-mass spectrometry, liquid chromatography-mass spectrometry, and gas chromatography-mass spectrometry.

### Claim 9 (depends on 6)

The method of claim 6, wherein the chemical analysis comprises determining the concentration of stizolobic acid in the biomass.

### Claim 10 (depends on 9)

The method of claim 9, wherein the biomass is selected for extraction if the concentration of stizolobic acid in the biomass is less than or equal to 100 μg/g.

### Claim 11 (depends on 9)

The method of claim 9, wherein the biomass is selected for extraction if the concentration of stizolobic acid in the biomass is less than or equal to 50 μg/g.

### Claim 12 (depends on 9)

The method of claim 9, wherein the chemical analysis comprises determining the concentration of stizolobinic acid in the biomass.

### Claim 13 (depends on 12)

The method of claim 12, wherein the biomass is selected for extraction if the concentration of stizolobinic acid in the biomass is less than or equal to 100 μg/g.

### Claim 14 (depends on 12)

The method of claim 12, wherein the biomass is selected for extraction if the concentration of stizolobinic acid in the biomass is less than or equal to 50 μg/g.

### Claim 15 (depends on 6)

The method of claim 6, wherein the chemical analysis comprises determining the concentration of any of cadmium, arsenic, lead, and mercury in the biomass.

### Claim 16 (depends on 6)

The method of claim 6, wherein the chemical analysis comprises inductively coupled plasma mass spectrometry.

### Claim 17 (depends on 15)

The method of claim 15, wherein the biomass is selected for extraction if the concentration of cadmium is less than or equal to about 2.0 ppm, 1.5 ppm, 1.0 ppm, or 0.5 ppm.

### Claim 18 (depends on 17)

The method of claim 17, wherein the biomass is selected for extraction if the concentration of cadmium is less than or equal to about 0.5 ppm.

### Claim 19 (depends on 15)

The method of claim 15, wherein the biomass is selected for extraction if the concentration of arsenic is less than or equal to about 5.0 ppm, 4.0 ppm, 3.0 ppm, 2.0 ppm, 1.5 ppm, 1.0 ppm, or 0.5 ppm.

### Claim 20 (depends on 19)

The method of claim 19, wherein the biomass is selected for extraction if the concentration of arsenic is less than or equal to about 1.5 ppm.

### Claim 21 (depends on 15)

The method of claim 15, wherein the biomass is selected for extraction if the concentration of lead is less than or equal to about 2.0 ppm, 1.5 ppm, 1.0 ppm, or 0.5 ppm.

### Claim 22 (depends on 21)

The method of claim 21, wherein the biomass is selected for extraction if the concentration of lead is less than or equal to about 0.5 ppm.

### Claim 23 (depends on 15)

The method of claim 15, wherein the biomass is selected for extraction if the concentration of mercury is less than or equal to about 5.0 ppm, 4.0 ppm, 3.0 ppm, 2.0 ppm, 1.5 ppm, 1.0 ppm, or 0.5 ppm.

### Claim 24 (depends on 23)

The method of claim 23, wherein the biomass is selected for extraction if the concentration of mercury is less than or equal to about 1.5 ppm.

### Claim 25 (depends on 6)

The method of claim 6, wherein the chemical analysis comprises testing for the presence of Amanita pantherina in the biomass.

### Claim 26 (depends on 25)

The method of claim 25, wherein the biomass is selected for extraction if the biomass comprises less than about 10%, 5%, 4%, 3%, 2%, or 1% (w/w) of Amanita pantherina.

### Claim 27 (depends on 25)

The method of claim 25, wherein the biomass is selected for extraction if the biomass is substantially free of Amanita pantherina.

### Claim 28 (depends on 6)

The method of claim 6, wherein the chemical analysis comprises determining the concentration of mycotoxins in the biomass.

### Claim 29 (depends on 28)

The method of claim 28, wherein the biomass is selected for extraction if the biomass comprises less than about 20 parts per billion (ppb) of a mycotoxin.

### Claim 30 (depends on 6)

The method of claim 6, wherein the chemical analysis comprises determining the concentration of pesticides in the biomass.

### Claim 31 (depends on 30)

The method of claim 30, wherein the biomass is selected for extraction if the biomass is substantially free of pesticides.

### Claim 32 (depends on 5)

The method of claim 5, wherein the analysis comprises an organoleptic analysis.

### Claim 33 (depends on 32)

The method of claim 32, wherein the organoleptic analysis comprises evaluating any of the visual appearance, smell, taste, and texture of the biomass.

### Claim 34 (depends on 5)

The method of claim 5, wherein the analysis comprises a microbiological analysis.

### Claim 35 (depends on 34)

The method of claim 34, wherein the microbiological analysis comprises any of testing the biomass for the presence of Salmonella spp., testing for the presence of Shiga-toxin producing Escherichia coli (STEC) bacteria, determining the total coliform count, and determining the total aerobic plate count, determining the total yeast and mold count in the biomass.

### Claim 36 (depends on 1)

The method of claim 1, wherein the aqueous extraction is performed in water heated to between about 70° C. and 100° C.

### Claim 37 (depends on 36)

The method of claim 36, wherein the aqueous extraction is performed in water heated to about 80° C.

### Claim 38 (depends on 1)

The method of claim 1, wherein the aqueous extraction is performed for between about 15 minutes and about 60 minutes.

### Claim 39 (depends on 1)

The method of claim 1, wherein filtering the extract comprises passing the extract through a membrane filter.

### Claim 40 (depends on 39)

The method of claim 39, wherein the membrane filter has a pore size of about 200 microns.

### Claim 41 (depends on 39)

The method of claim 39, wherein the membrane filter is a sock filter.

### Claim 42 (depends on 41)

The method of claim 41, wherein filtering the extract comprises passing the extract through two 200-micron sock filters in a parallel configuration.

### Claim 43 (depends on 1)

The method of claim 1, wherein the pH of the extract is reduced to between about 2.0 and 3.0.

### Claim 44 (depends on 43)

The method of claim 43, wherein the pH of the extract is reduced to between about 2.4 and 2.6.

### Claim 45 (depends on 1)

The method of claim 1, wherein the pH of the extract is reduced using a mineral acid.

### Claim 46 (depends on 45)

The method of claim 45, wherein the mineral acid is hydrochloric acid.

### Claim 47 (depends on 1)

The method of claim 1, wherein the extract is refluxed at a temperature of between about 95° C. and 100° C.

### Claim 48 (depends on 1)

The method of claim 1, wherein the extract is refluxed for between about 4.25 and 4.75 hours.

### Claim 49 (depends on 48)

The method of claim 48, wherein the extract is refluxed for about 4.5 hours.

### Claim 50 (depends on 1)

The method of claim 1, wherein refluxing the extract reduces the concentration of ibotenic acid and increases the concentration of muscimol in the extract.

### Claim 51 (depends on 1)

The method of claim 1, further comprising increasing the pH of the extract.

### Claim 52 (depends on 51)

The method of claim 51, wherein the pH of the extract is increased to between about 3.5 and 4.5.

### Claim 53 (depends on 52)

The method of claim 52, wherein the pH of the extract is increased to about 4.

### Claim 54 (depends on 51)

The method of claim 51, wherein the pH of the extract is increased by the addition of a hydroxide base.

### Claim 55 (depends on 1)

The method of claim 1, wherein the pH of the extract is increased by the addition of sodium hydroxide pellets.

### Claim 56 (depends on 1)

The method of claim 1, wherein the weight ratio of muscimol to ibotenic acid in the refluxed extract is between about 10:1 and 200:1.

### Claim 57 (depends on 1)

The method of claim 1, wherein the weight ratio of muscimol to ibotenic acid in the refluxed extract is between about 10:1 and 100:1.

### Claim 58 (depends on 1)

The method of claim 1, wherein the weight ratio of muscimol to ibotenic acid in the refluxed extract is between about 10:1 and 50:1.

### Claim 59 (depends on 1)

The method of claim 1, wherein the weight ratio of muscimol to ibotenic acid in the refluxed extract is between about 10:1 and 25:1.

### Claim 60 (depends on 1)

The method of claim 1, wherein the weight ratio of muscimol to ibotenic acid in the refluxed extract is between about 10:1 and 15:1.

### Claim 61 (depends on 1)

The method of claim 1, wherein the refluxed extract comprises between about 100 and 130 μg/g of muscimol, between about 7 and 10 μg/g of muscarine, and between about 4 and 12 μg/g of ibotenic acid.

### Claim 62 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61)

An extract of Amanita muscaria mushroom biomass obtained by the method of any one of claims 1-61.

### Claim 63 (depends on 62)

The extract of claim 62, comprising muscimol and ibotenic acid in a weight ratio of between about 10:1 and 200:1.

### Claim 64 (depends on 63)

The extract of claim 63, comprising muscimol and ibotenic acid in a weight ratio of between about 10:1 and 100:1.

### Claim 65 (depends on 64)

The extract of claim 64, comprising muscimol and ibotenic acid in a weight ratio of between about 10:1 and 50:1.

### Claim 66 (depends on 65)

The extract of claim 65, comprising muscimol and ibotenic acid in a weight ratio of between about 10:1 and 25:1.

### Claim 67 (depends on 66)

The extract of claim 66, comprising muscimol and ibotenic acid in a weight ratio of between about 10:1 and 15:1.

### Claim 68 (depends on 62)

The extract of claim 62, comprising between about 100 and 130 μg/g of muscimol, between about 7 and 10 μg/g of muscarine, and between about 4 and 12 μg/g of ibotenic acid.

### Claim 69 (depends on 62)

The extract of any claim 62, further comprising a preservative.

### Claim 70 (depends on 69)

The extract of claim 69, wherein the preservative is sodium benzoate, potassium sorbate, or a combination thereof.

### Claim 71 (depends on 62)

The extract of claim 62, further comprising a flavoring agent.

### Claim 72 (depends on 71)

The extract of claim 71, wherein the flavoring agent is a corn flavor.

### Claim 73 (depends on 62)

A beverage formulation comprising the extract of claim 62.

### Claim 74 (depends on 73)

The beverage formulation of claim 73, further comprising a flavoring agent.

### Claim 75 (depends on 74)

The beverage formulation of claim 74, wherein the flavoring agent is a flavor of plum, prune, date, currant, fig, grape, raisin, cranberry, pineapple, peach, nectarine, banana, apple, pear, guava, apricot, Saskatoon berry, blueberry, plains berry, prairie berry, mulberry, elderberry, Barbados cherry (acerola cherry), choke cherry, chocolate, vanilla, caramel, coconut, olive, raspberry, strawberry, huckleberry, loganberry, dewberry, boysenberry, kiwi, cherry, blackberry, honey dew, green tea, cucumber, quince, buckthorn, passion fruit, sloe, rowan, gooseberry, pomegranate, persimmon, mango, rhubarb, papaya, litchi, lemon, orange, lime, tangerine, mandarin and grapefruit juices, or any combination thereof.

### Claim 76 (depends on 75)

The beverage formulation of claim 75, wherein the flavoring agent is a mango flavor.

### Claim 77 (depends on 73)

The beverage formulation of claim 73, further comprising magnesium.

### Claim 78 (depends on 73)

The beverage formulation of claim 73, further comprising L-theanine.

### Claim 79 (depends on 62)

A dietary supplement comprising the extract of claim 62.

### Claim 80 (depends on 62)

An edible formulation comprising the extract of claim 62.

### Claim 81 (depends on 80)

The edible formulation of claim 80, wherein the edible formulation is a gummy.

### Claim 82 (depends on 90)

The edible formulation of claim 90, wherein the edible formulation is a liquid tincture.

### Claim 83 (depends on 62)

A topical formulation comprising the extract of any claim 62.

### Claim 84 (depends on 83)

The topical formulation of claim 83, wherein the topical formulation is a skin cream.

### Claim 85 (depends on 62)

A vaporizer formulation comprising the extract of claim 62.
